Churg-strauss vasculitis in a patient treated with omalizumab

Journal of Asthma

Volumn 45, Issue 2, 2008, Pages 115-116

  Bargagli, Elana ^a   Madioni, Chiara ^a   Olivieri, Carmela ^a   Penza, Francesco ^a   Rottoli, Paola ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Anti IgE; Asthma; Churg Strauss syndrome; Omalizumab

Indexed keywords

AZATHIOPRINE; OMALIZUMAB; PREDNISONE; STEROID;

ADULT; ALLERGIC ASTHMA; ARTICLE; CASE REPORT; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; LOW DRUG DOSE; MALE; VASCULITIS;

ANTI-ASTHMATIC AGENTS; ANTIBODIES, MONOCLONAL; ASTHMA; AZATHIOPRINE; CHURG-STRAUSS SYNDROME; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREDNISONE; TREATMENT OUTCOME;

EID: 40949159853     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900701767704     Document Type: Article

References (16)

1. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951; 27:277-301.
2. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984; 63:65-81.
3. Jenette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-192.
4. Finan MC, Winkelmann RK. The cutaneous extravascular necrotizing granuloma. (Churg-Strauss granuloma) and systemic disease: a review of 27 cases. Medicine (Baltimore) 1983; 62:142-158.
5. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999; 78:26-37.
6. The America College of Rheumatology criteria for diagnosis of Churg-Strauss syndrome. Arthritis Rheum 1990; 33:1094-1100.
7. Nakamura Y, Sakurai y, Matsubara T, Nagai T, Fukaya S, Imazu H, et al. Multiple perforated ulcers of the small intestine associated with allergic granulomatous angiitis. Surg Today 2002; 32:541-546.
8. Guillevin L, Lhote F, Gauraud M, Cohen P, Jarrousse B, Lortholary O, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. Medicine 1996; 75:17-28.
9. Gayraud M, Guillevin L, Toumelin PL, Cohen P, Lhote F, Casassus P, et al. Long-term follow-up of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Arthritis Rheum 2001; 44:666-675.
10. MacGlashan DJ, Shroeder JT. Functional consequences of Fc epsilon RIalpha up-regulation by IgE in human basophils. J Leuk Biol 2000; 68:479-486.
11. Rolinck-Werninghaus C, Whan U, Hamelmann E. Anti-IgE therapy in allergic asthma. Curr Drug Targets Inflam Allergy 2005; 4:551-564.
12. Giavina Bianchi P, Giavina Bianchi M, Agondi R, Kalil J. Three months' administration of anti-IgE to a patient with Churg-Strauss syndrome. J Allergy Clin Immunol 2007;119:1279-1280.
13. Winchester DE, Jacob A, Murphy T. Omalizumab for asthma. N Engl J Med 2006; 355:1281-1282.
14. Bargagli E, Rottoli P. Omalizumab treatment associated with Churg-Strauss. Int Arch Allergy Immunol 2007; 145:268.
15. Weller FP, Plaut M, Taggart V, Trontell A. The relationship of asthma therapy and Churg-Strauss syndrome. NIH workshop summary report. J Allergy Clin Immunol 2001; 108:175-183.
16. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategies for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143-178.